Современные аспекты реваскуляризации миокарда при хронических окклюзиях коронарного русла

Хронические окклюзии коронарного русла встречаются в 16-18,4% случаев согласно результатам наблюдательных исследований и регистров. Традиционно эндоваскулярные реваскуляризации при окклюзиях считаются менее подходящей стратегией. Кардиологи чаще предпочитают медикаментозную терапию. Результаты научных исследований убедительно показали, что неполная реваскуляризация миокарда после безуспешной реканализации окклюзий приводит к более худшему отдаленному прогнозу. Благодаря накопленному опыту и новому техническому оснащению частота успеха реканализации окклюзий коронарного русла достигла 87-95%. Это позволяет в большем количестве случаев добиться полной реваскуляризации миокарда и, безусловно, служит поводом для пересмотра консервативного подхода к окклюзиям в пользу более активного подхода. В связи с этим существует большая потребность в рандомизированных клинических исследованиях для оценки влияния эндоваскулярной реваскуляризации при хронических окклюзиях.

1. Farooq V, Serruys PW, Garcia-Garcia HM, et al. The negative impact of incomplete angiographic revascularization on clinical outcomes and its association with total occlusions: the SYNTAX (Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) trial. JACC. 2013;61(3):282-94. doi:10.1016/j.jacc.2012.10.017

2. Di Mario C, Werner GS, Sianos G, et al. European perspective in the recanalisation of Chronic Total Occlusions (CTO): consensus document from the EuroCTO Club. Euro Intervention. 2007;3(1):30-43.

3. Fefer P, Knudtson ML, Cheema AN, et al. Current perspectives on coronary chronic total occlusions: the Canadian Multicenter Chronic Total Occlusions Registry. JACC. 2012;59(11):991-7 doi:10.1016/j.jacc.2011.12.007.

4. Ramunddal T, Hoebers LP, Henriques JP, et al. Chronic total occlusions in Sweden-a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR). PLoS One. 2014;9(8):e103850. doi:10.1371/journal.pone.0103850.

5. Strauss BH, Shuvy M, Wijeysundera HC. Revascularization of chronic total occlusions: time to reconsider? JACC. 2014;64(12):1281-9. doi:10.1016/j.jacc.2014.06.1181.

6. Brilakis ES, Grantham JA, Rinfret S, et al. A percutaneous treatment algorithm for crossing coronary chronic total occlusions. JACC Cardiovasc Interv. 2012;5(4):367-79. doi:10.1016/j.jcin.2012.02.006.

7. Brilakis ES, Banerjee S, Karmpaliotis D, et al. Procedural outcomes of chronic total occlusion percutaneous coronary intervention: a report from the NCDR (National Cardiovascular Data Registry). JACC Cardiovasc Interv. 2015;8(2):245-53. doi:10.1016/j.jcin.2014.08.014.

8. Maeremans J, Walsh S, Knaapen P, et al. The hybrid algorithm for treating chronic total occlusions in Europe: the RECHARGE registry. JACC. 2016;68(18): 1958-70. doi:10.1016/j.jacc.2016.08.034.

9. Nombela-Franco L, Urena M, Jerez-Valero M, et al. Validation of the J-chronic total occlusion score for chronic total occlusion percutaneous coronary intervention in an independent contemporary cohort. Circ Cardiovasc Interv. 2013;6(6):635-43. doi:10.1161/CIRCINTERVENTIONS.114.002171.

10. Christopoulos G, Karmpaliotis D, Alaswad K, et al. Application and outcomes of a hybrid approach to chronic total occlusion percutaneous coronary intervention in a contemporary multicenter US registry. Int J Cardiol. 2015;198:222-8. doi:10.1016/j.ijcard.2015.06.093.

11. Habib GB, Heibig J, Forman SA, et al. Influence of coronary collateral vessels on myocardial infarct size in humans. Results of phase I thrombolysis in myocardial infarction (TIMI) trial. The TIMI Investigators. Circulation. 1991;83(3):739-46. doi:10.1161/01.cir.83.3.739.

12. Di Marco A, Anguera I, Teruel L, et al. Chronic total occlusion in an infarct-related coronary artery and the risk of appropriate ICD therapies. J Cardiovasc Electrophysiol. 2017;28(10):1169-78. doi:10.1111/jce.13290.

13. Di Marco A, Paglino G, Oloriz T, et al. Impact of a chronic total occlusion in an infarct-related artery on the long-term outcome of ventricular tachycardia ablation. J Cardiovasc Electrophysiol. 2015;26(5):532-9. doi:10.1111/jce.12622.

14. Neumann FJ, Sousa-Uva M, Ahlsson A, et al. ESC Scientific Document Group. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40(2):87-165. doi:10.1093/eurheartj/ehy394.

15. Windecker S, Kolh P, Alfonso F, et al. 2014 ESC/EACTS guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014;35(37):2541-619. doi:10.1093/eurheartj/ehu278.

16. Patel MR, Calhoon JH, Dehmer GJ, et al. ACC/ AATS/AHA/ASE/ASNC/SCAI/SCCT/ STS 2017 appropriate use criteria for coronary revascularization in patients with stable ischemic heart disease: a report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society of Thoracic Surgeons. JACC. 2017;69(17):2212-41. doi:10.1007/s12350-017-0917-9.

17. Hachamovitch R, Hayes SW, Friedman JD, et al. Comparison of the shortterm survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation. 2003;107(23):2900-7. doi:10.1161/01.CIR.0000072790.23090.41.

18. Stuijfzand WJ, Driessen RS, Raijmakers PG, et al. Prevalence of ischaemia in patients with a chronic total occlusion and preserved left ventricular ejection fraction. Eur Heart J Cardiovasc Imaging. 2017;18(9):1025-33. doi:10.1093/ehjci/jew188.

19. Sachdeva R, Agrawal M, Flynn SE, et al. The myocardium supplied by a chronic total occlusion is a persistently ischemic zone. Catheter Cardiovasc Interv. 2014;83(1):9-16. doi:10.1002/ccd.25001.

20. Stuijfzand WJ, Biesbroek PS, Raijmakers PG, et al. Effects of successful percutaneous coronary intervention of chronic total occlusions on myocardial perfusion and left ventricular function. Euro Intervention. 2017;13(3):345-54. doi:10.4244/EIJ-D-16-01014.

21. Galassi AR, Werner GS, Tomasello SD, et al. Prognostic value of exercise myocardial scintigraphy in patients with coronary chronic total occlusions. J Interv Cardiol. 2010;23(2):139-48. doi:10.1111/j.1540-8183.2010.00527.

22. Baks T, van Geuns RJ, Duncker DJ, et al. Prediction of left ventricular function after drug-eluting stent implantation for chronic total coronary occlusions. J Am Coll Cardiol2006;47(4):721-5. doi:10.1016/j.jacc.2005.10.042.

23. Stuijfzand WJ, Raijmakers PG, Driessen RS, et al. Value of hybrid imaging with PET/CT to guide percutaneous revascularization of chronic total coronary occlusion. Curr Cardiovasc Imaging Rep. 2015;8(7):26. doi: 10.1016/j.carrev.2018.07.025.

24. Watanabe H, Morimoto T, Shiomi H, et al. Chronic total occlusion in a non-infarct-related artery is closely associated with increased five-year mortality in patients with ST-segment elevation acute myocardial infarction undergoing primary percutaneous coronary intervention (from the CREDOKyoto AMI registry). Euro Intervention. 2017;12(15):e1874-82. doi:10.1002/ccd.27330.

25. Fujii T, Sakai K, Nakano M, et al. Impact of the origin of the collateral feeding donor artery on short-term mortality in ST-elevation myocardial infarction with comorbid chronic total occlusion. Int J Cardiol. 2016;218:158-63. doi: 10.1016/j.carrev.2018.07.025.

26. Henriques JP, Hoebers LP, Ramunddal T, et al. Percutaneous intervention for concurrent chronic total occlusions in patients with STEMI: the EXPLORE trial. JACC. 2016;68(15):1622-32. doi:10.1016/j.jacc.2016.07.744.

27. Elias J, van Dongen IM, Hoebers LP, et al. Improved recovery of regional left ventricular function after PCI of chronic total occlusion in STEMI patients: a cardiovascular magnetic resonance study of the randomized controlled EXPLORE trial. J Cardiovasc Magn Reson. 2017;19(1):53. doi:10.1186/s12968-017-0369-z.

28. Christakopoulos GE, Christopoulos G, Carlino M, et al. Meta-analysis of clinical outcomes of patients who underwent percutaneous coronary interventions for chronic total occlusions. Am J Cardiol. 2015;115(10):1367-75. doi:10.1016/j.amjcard.2015.02.038.

29. Safley DM, Grantham JA, Hatch J, et al. Quality of life benefits of percutaneous coronary intervention for chronic occlusions. Catheter Cardiovasc Interv. 2014;84(4):629-34. doi:10.1002/ccd.25303.

30. Rossello X, Pujadas S, Serra A, et al. Assessment of inducible myocardial ischemia, quality of life, and functional status after successful percutaneous revascularization in patients with chronic total coronary occlusion. Am J Cardiol. 2016;117(5):720-6. doi:10.1016/j.amjcard.2015.12.001.

31. Hoebers LP, Claessen BE, Elias J, et al. Meta-analysis on the impact of percutaneous coronary intervention of chronic total occlusions on left ventricular function and clinical outcome. Int J Cardiol. 2015;187:90-6. doi:10.1016/j.ijcard.2015.03.164.

32. Galassi AR, Boukhris M, Toma A, et al. Percutaneous coronary intervention of chronic total occlusions in patients with low left ventricular ejection fraction. JACC Cardiovasc Interv. 2017;10(21):2158-70. doi:10.1016/j.jcin.2017.06.058.

33. Toma A, Gebhard C, Gick M, et al. Survival after percutaneous coronary intervention for chronic total occlusion in elderly patients. Euro Intervention. 2017;13(2):e228-35. doi:10.4244/EIJ-D-16-00499.

34. Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. Circulation. 2011;124:e574-651. doi:10.1161/CIR.0b013e31823ba622.

35. Hochman JS, Lamas GA, Buller CE, et al. Occluded Artery Trial Investigators. Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med. 2006;355(23):2395-407. Epub 2006 Nov 14. doi:10.1056/NEJMoa066139.

36. Seung-Whan Lee, Pil Hyung Lee, Jung-Min Ahn, et al. Randomized Trial Evaluating Percutaneous Coronary Intervention for the Treatment of Chronic Total Occlusion. The DECISION-CTO Trial. Circulation. 2019;139:1674-83. doi:10.1161/CIRCULATIONAHA.118.031313.

37. Werner GS, Martin-Yuste V, Hildick-Smith D, et al. A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions. Eur Heart J. 2018. doi:10.1093/eurheartj/ehy220.